From: The remarkable history of pneumococcal vaccination: an ongoing challenge
• Burden of pneumococcal disease varies in different regions |
 - Different rates of risk factors such as smoking, HIV, other comorbidities in the population or community |
• Herd protection may be different geographically as may the residual burden of disease |
 - Different susceptibilities of the hosts, which childhood vaccines are used, and their coverage rate, force of transmission, proportion of disease caused by vaccine serotype |
• Does herd protection have a limit? |
• Decline of PCV13 serotypes in adults is attenuated by older age and comorbidity |
• Underestimation of residual pneumococcal disease |
 - Especially of non-invasive infection, and/or when using conventional microbiological methods only |
• Serotype replacement disease |
 - Varies in different countries |